Literature DB >> 31296695

Effect of intrapartum antibiotics on the intestinal microbiota of infants: a systematic review.

Petra Zimmermann1,2,3,4, Nigel Curtis2,3,4.   

Abstract

INTRODUCTION: The use of intrapartum antibiotic prophylaxis (IAP) has become common practice in obstetric medicine and is used in up to 40% of deliveries. Despite its benefits, the risks associated with exposing large numbers of infants to antibiotics, especially long-term effects on health through changes in the microbiota, remain unclear. This systematic review summarises studies that have investigated the effect of IAP on the intestinal microbiota of infants.
METHODS: A systematic search in Ovid MEDLINE was used to identify original studies that investigated the effect of IAP on the intestinal microbiota in infants. Studies were excluded if: they included preterm infants, the antibiotic regimen was not specified, antibiotics were used for indications other than prophylaxis, probiotics were given to mothers or infants, or antibiotics were given to infants.
RESULTS: We identified six studies, which investigated a total of 272 infants and included 502 stool samples collected up to 3 months of age. In all the studies, IAP was given for group B streptococcus (GBS) colonisation. Infants who were exposed to GBS IAP had a lower bacterial diversity, a lower relative abundance of Actinobacteria, especially Bifidobacteriaceae, and a larger relative abundance of Proteobacteria in their intestinal microbiota compared with non-exposed infants. Conflicting results were reported for the phyla Bacteroidetes and Firmicutes.
CONCLUSIONS: GBS IAP has profound effects on the intestinal microbiota of infants by diminishing beneficial commensals. Such changes during the early-life 'critical window' during which the intestinal microbiota and the immune response develop concurrently may have an important influence on immune development. The potential long-term adverse consequences of this on the health of children warrant further investigation. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  16srna; delivery; microbiome; neonate; prophylaxis

Year:  2019        PMID: 31296695     DOI: 10.1136/archdischild-2018-316659

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  17 in total

Review 1.  Probiotic supplementation for neonates with congenital gastrointestinal surgical conditions: guidelines for future research.

Authors:  Shripada Rao; Meera Esvaran; Liwei Chen; Chooi Kok; Anthony D Keil; Ian Gollow; Karen Simmer; Bernd Wemheuer; Patricia Conway; Sanjay Patole
Journal:  Pediatr Res       Date:  2022-05-03       Impact factor: 3.756

2.  Maternal antibiotics disrupt microbiome, behavior, and temperature regulation in unexposed infant mice.

Authors:  Christopher Harshaw; Sayuri Kojima; Cara L Wellman; Gregory E Demas; Ardythe L Morrow; Diana Hazard Taft; William M Kenkel; Joseph K Leffel; Jeffrey R Alberts
Journal:  Dev Psychobiol       Date:  2022-09       Impact factor: 2.531

3.  Probiotic supplementation in neonates with congenital gastrointestinal surgical conditions: a pilot randomised controlled trial.

Authors:  Shripada Rao; Meera Esvaran; Liwei Chen; Anthony D Keil; Ian Gollow; Karen Simmer; Bernd Wemheuer; Patricia Conway; Sanjay Patole
Journal:  Pediatr Res       Date:  2022-01-03       Impact factor: 3.953

4.  Galacto-Oligosaccharide Supplementation Modulates Pathogen-Commensal Competition between Streptococcus agalactiae and Streptococcus salivarius.

Authors:  Rebecca E Moore; Harrison C Thomas; Shannon D Manning; Jennifer A Gaddy; Steven D Townsend
Journal:  Chembiochem       Date:  2021-11-29       Impact factor: 3.461

5.  Comparing Gut Microbiome in Mothers' Own Breast Milk- and Formula-Fed Moderate-Late Preterm Infants.

Authors:  Ziyi Wang; Achal Neupane; Richard Vo; Jessica White; Xiuqing Wang; Shin-Yi Lee Marzano
Journal:  Front Microbiol       Date:  2020-05-26       Impact factor: 5.640

6.  Study protocol for the ABERRANT study: antibiotic-induced disruption of the maternal and infant microbiome and adverse health outcomes - a prospective cohort study among children born at term.

Authors:  Maryse Volery; Valentin Scherz; William Jakob; Diane Bandeira; Vanessa Deggim-Messmer; Anna Lauber-Biason; Johannes Wildhaber; Laurent Falquet; Nigel Curtis; Petra Zimmermann
Journal:  BMJ Open       Date:  2020-06-23       Impact factor: 2.692

Review 7.  Regulating Gut Microbiome: Therapeutic Strategy for Rheumatoid Arthritis During Pregnancy and Lactation.

Authors:  Yao Yao; Xiaoyu Cai; Weidong Fei; Fujia Ren; Fengmei Wang; Xiaofei Luan; Fengying Chen; Caihong Zheng
Journal:  Front Pharmacol       Date:  2020-11-11       Impact factor: 5.810

8.  Maternal Antibiotic Treatment Disrupts the Intestinal Microbiota and Intestinal Development in Neonatal Mice.

Authors:  Chung-Ming Chen; Hsiu-Chu Chou; Yu-Chen S H Yang
Journal:  Front Microbiol       Date:  2021-06-04       Impact factor: 5.640

Review 9.  Recent advances in understanding the neonatal microbiome.

Authors:  Matthew J Dalby; Lindsay J Hall
Journal:  F1000Res       Date:  2020-05-22

10.  A synbiotic intervention modulates meta-omics signatures of gut redox potential and acidity in elective caesarean born infants.

Authors:  Christophe Lay; Collins Wenhan Chu; Rikky Wenang Purbojati; Enzo Acerbi; Daniela I Drautz-Moses; Paola Florez de Sessions; Song Jie; Eliza Ho; Yee Jiun Kok; Xuezhi Bi; Shuwen Chen; Shi Ya Mak; Mei Chien Chua; Anne E N Goh; Wen Chin Chiang; Rajeshwar Rao; Surasith Chaithongwongwatthana; Nipon Khemapech; Voranush Chongsrisawat; Rocio Martin; Guus Roeselers; Ying Swan Ho; Martin L Hibberd; Stephan C Schuster; Jan Knol
Journal:  BMC Microbiol       Date:  2021-06-25       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.